Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(4.87)
# 70
Out of 5,093 analysts
25
Total ratings
82.35%
Success rate
61.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Equal-Weight | $17 → $25 | $25.81 | -3.12% | 3 | Nov 19, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Equal-Weight | $8 → $11 | $18.72 | -41.24% | 3 | Nov 11, 2025 | |
| RLAY Relay Therapeutics | Maintains: Equal-Weight | $4 → $6 | $7.58 | -20.84% | 1 | Nov 7, 2025 | |
| IMCR Immunocore Holdings | Initiates: Overweight | $60 | $36.54 | +64.20% | 1 | Oct 31, 2025 | |
| RCUS Arcus Biosciences | Maintains: Overweight | $25 → $29 | $25.07 | +15.68% | 4 | Oct 20, 2025 | |
| MRUS Merus | Downgrades: Equal-Weight | $95 → $97 | $96.36 | +0.66% | 5 | Sep 30, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Overweight | $42 → $45 | $41.18 | +9.28% | 3 | Sep 25, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $67 → $70 | $77.81 | -10.04% | 1 | Sep 11, 2025 | |
| XNCR Xencor | Maintains: Overweight | $33 → $27 | $16.81 | +60.62% | 3 | Aug 7, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Overweight | $44 | $34.08 | +29.11% | 1 | Jun 26, 2025 |
Zymeworks
Nov 19, 2025
Maintains: Equal-Weight
Price Target: $17 → $25
Current: $25.81
Upside: -3.12%
Bicara Therapeutics
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $18.72
Upside: -41.24%
Relay Therapeutics
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $4 → $6
Current: $7.58
Upside: -20.84%
Immunocore Holdings
Oct 31, 2025
Initiates: Overweight
Price Target: $60
Current: $36.54
Upside: +64.20%
Arcus Biosciences
Oct 20, 2025
Maintains: Overweight
Price Target: $25 → $29
Current: $25.07
Upside: +15.68%
Merus
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $95 → $97
Current: $96.36
Upside: +0.66%
Kiniksa Pharmaceuticals International,
Sep 25, 2025
Maintains: Overweight
Price Target: $42 → $45
Current: $41.18
Upside: +9.28%
Revolution Medicines
Sep 11, 2025
Maintains: Overweight
Price Target: $67 → $70
Current: $77.81
Upside: -10.04%
Xencor
Aug 7, 2025
Maintains: Overweight
Price Target: $33 → $27
Current: $16.81
Upside: +60.62%
IDEAYA Biosciences
Jun 26, 2025
Initiates: Overweight
Price Target: $44
Current: $34.08
Upside: +29.11%